Patent details

Basic Information

Publication number:

EP2994167

PCT Application Number:

US2014036915

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147951537

PCT Publication Number:

WO2014182661

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES

French Title of Invention:

DOSAGES ET MÉTHODES POUR ADMINISTRER DES MOLÉCULES D'ACIDES NUCLÉIQUES À FORMULATION LIPIDIQUE

German Title of Invention:

DOSIERUNGEN UND VERFAHREN ZUR ABGABE VON LIPIDFORMULIERTEN NUKLEINSÄUREMOLEKÜLEN

SPC Number:

Dates

Filing date:

06/05/2014

Grant date:

06/05/2020

EP Publication Date:

16/03/2016

PCT Publication Date:

13/11/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/05/2020

EP B1 Publication Date:

06/05/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/05/2020

Expiration date:

06/05/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/04/2020

 

 

Name:

Alnylam Pharmaceuticals, Inc.

Address:

300 Third Street, 3rd Floor, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

GOLLOB, Jared

Address:

United States (US)

2

Name:

KASPERKOVITZ, Pia

Address:

United States (US)

Priority

Priority Number:

201361820036 P

Priority Date:

06/05/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/127; A61K 48/00; C12N 15/88; C12N 15/113;

Publication

European Patent Bulletin

Issue number:

202019

Publication date:

06/05/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages